People · Operator
Named in public records as an officer, director or promoter · active 2010–2021 · Healthtech, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Autonomous Medical Devices Inc | — | Healthtech | Series D+ | $142.4M | $2.8B | 2021 |
| Exosome Diagnostics, Inc. | — | Biotechnology | Series B | $90.9M | $1.2B | 2012 |
| Quanterix Corp | — | Other Technology | Series C | $71.8M | $194.1M | 2010 |
| Brava Diagnostics, Inc. | — | Biotechnology | Seed | $4.3M | $11.1M | 2018 |
David Okrongly at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Okrongly on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Connolly | 1 | 14 |
| Paul Meister | 1 | 12 |
| Keith Crandell | 1 | 11 |
| David Walt | 1 | 6 |
| John M. Connolly | 1 | 6 |
| Thomas Chen | 1 | 5 |
| Josh Shachar | 1 | 5 |
| Douglas Cole | 1 | 5 |
| William Kelly | 1 | 5 |
| Robert Silverman | 1 | 5 |
| Georg Nebgen | 1 | 5 |
| Frank Adell | 1 | 5 |
| David R. Walt | 1 | 5 |
| PAUL M MEISTER | 1 | 4 |
| Roger Kornberg | 1 | 4 |
| John Boyce | 1 | 4 |
| Marijn Dekkers | 1 | 4 |
| Paul Marinelli | 1 | 4 |
| Paul Chapman | 1 | 3 |
| Martin Madaus | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.